The Grace Therapeutics brand, founded in 2014 (United States), from 1 sister brand and 2214 competing brands. Grace Therapeutics is owned by Acasti Pharma Inc., listed on the stock exchange of New York The International Securities Identification Number (ISIN) of Acasti Pharma Inc. is CA00430K8730. Grace Therapeutics is part of the Biotechnology activity sector.

Grace Therapeutics is a brand of Acasti Pharma Inc. (ACST) Share price

Share price and profitability of the share Acasti Pharma Inc. (Grace Therapeutics)

Buy Acasti Pharma Inc. share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 3.44

Portfolio valuation
Acasti Pharma Inc. (Grace Therapeutics) over 5 years* USD 0.24

Stock market history Acasti Pharma Inc. (Grace Therapeutics)

Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more